Fig. 1From: The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover studyPre-exercise NT-proBNP values at day 90. The values were significantly lower under the treatment with pimobendan than under the treatment with placebo (p = 0.033)Back to article page